These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 2919369)

  • 1. Chloral hydrate anesthesia alters the responsiveness of identified midbrain dopamine neurons to dopamine agonist administration.
    Kelland MD; Freeman AS; Chiodo LA
    Synapse; 1989; 3(1):30-7. PubMed ID: 2919369
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of (+)-4-propyl-9-hydroxynaphthoxazine on midbrain dopamine neurons: an electrophysiological study.
    Kelland MD; Freeman AS; LeWitt PA; Chiodo LA
    J Pharmacol Exp Ther; 1990 Oct; 255(1):276-84. PubMed ID: 1976800
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Electrophysiological and pharmacological characterization of identified nigrostriatal and mesoaccumbens dopamine neurons in the rat.
    Clark D; Chiodo LA
    Synapse; 1988; 2(5):474-85. PubMed ID: 2903568
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SKF 38393 alters the rate-dependent D2-mediated inhibition of nigrostriatal but not mesoaccumbens dopamine neurons.
    Kelland MD; Freeman AS; Chiodo LA
    Synapse; 1988; 2(4):416-23. PubMed ID: 2973142
    [TBL] [Abstract][Full Text] [Related]  

  • 5. D1 dopamine receptor stimulation enables the postsynaptic, but not autoreceptor, effects of D2 dopamine agonists in nigrostriatal and mesoaccumbens dopamine systems.
    Wachtel SR; Hu XT; Galloway MP; White FJ
    Synapse; 1989; 4(4):327-46. PubMed ID: 2532422
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Repeated stimulation of dopamine D2-like receptors: reduced responsiveness of nigrostriatal and mesoaccumbens dopamine neurons to quinpirole.
    Pitts DK; Wang L; Kelland MD; Freeman AS; Chiodo LA
    J Pharmacol Exp Ther; 1995 Oct; 275(1):412-21. PubMed ID: 7562579
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ontogeny of nigrostriatal dopamine neuron autoreceptors: iontophoretic studies.
    Wang L; Pitts DK
    J Pharmacol Exp Ther; 1995 Jan; 272(1):164-76. PubMed ID: 7815330
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Electrophysiological characteristics and pharmacological responsiveness of midbrain dopaminergic neurons of the aged rat.
    Freeman AS; Kelland MD; Rouillard C; Chiodo LA
    J Pharmacol Exp Ther; 1989 Jun; 249(3):790-7. PubMed ID: 2567352
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Repeated amphetamine administration: role of forebrain in reduced responsiveness of nigrostriatal dopamine neurons to dopamine agonists.
    Pitts DK; Kelland MD; Freeman AS; Chiodo LA
    J Pharmacol Exp Ther; 1993 Feb; 264(2):616-21. PubMed ID: 8094749
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Electrophysiological and pharmacological characteristics of nigral dopaminergic neurons in the conscious, head-restrained rat.
    Fà M; Mereu G; Ghiglieri V; Meloni A; Salis P; Gessa GL
    Synapse; 2003 Apr; 48(1):1-9. PubMed ID: 12557266
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serotonergic afferent regulation of the basic physiology and pharmacological responsiveness of nigrostriatal dopamine neurons.
    Kelland MD; Freeman AS; Chiodo LA
    J Pharmacol Exp Ther; 1990 May; 253(2):803-11. PubMed ID: 1971022
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nigrostriatal lesion alters neurophysiological responses to selective and nonselective D-1 and D-2 dopamine agonists in rat globus pallidus.
    Carlson JH; Bergstrom DA; Demo SD; Walters JR
    Synapse; 1990; 5(2):83-93. PubMed ID: 2309160
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dopamine neuron ontogeny: electrophysiological studies.
    Pitts DK; Freeman AS; Chiodo LA
    Synapse; 1990; 6(4):309-20. PubMed ID: 1981111
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contribution of the amygdala and nucleus accumbens to ventral pallidal responses to dopamine agonists.
    Napier TC
    Synapse; 1992 Feb; 10(2):110-9. PubMed ID: 1350111
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurophysiological investigation of effects of the D-1 agonist SKF 38393 on tonic activity of substantia nigra dopamine neurons.
    Carlson JH; Bergstrom DA; Weick BG; Walters JR
    Synapse; 1987; 1(5):411-6. PubMed ID: 2975067
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Electrophysiological effects of SKF 38393 in rats with reserpine treatment and 6-hydroxydopamine-induced nigrostriatal lesions reveal two types of plasticity in D1 dopamine receptor modulation of basal ganglia output.
    Huang KX; Walters JR
    J Pharmacol Exp Ther; 1994 Dec; 271(3):1434-43. PubMed ID: 7996456
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dopamine agonists at repeated "autoreceptor-selective" doses: effects upon the sensitivity of A10 dopamine autoreceptors.
    Jeziorski M; White FJ
    Synapse; 1989; 4(4):267-80. PubMed ID: 2603146
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microiontophoretic studies of the effects of D-1 and D-2 receptor agonists on type I caudate nucleus neurons: lack of synergistic interaction.
    Shen RY; Asdourian D; Chiodo LA
    Synapse; 1992 Aug; 11(4):319-29. PubMed ID: 1354398
    [TBL] [Abstract][Full Text] [Related]  

  • 19. D1 receptor stimulation inhibits dopamine cell activity after reserpine treatment but not after chronic SCH 23390: an effect blocked by N-methyl-D-aspartate antagonists.
    Huang KX; Walters JR
    J Pharmacol Exp Ther; 1992 Jan; 260(1):409-16. PubMed ID: 1530977
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Electrophysiological evaluation of a partial agonist of dopamine receptors.
    Piercey MF; Hoffmann WE; Vogelsang GD; Travis M
    J Pharmacol Exp Ther; 1987 Oct; 243(1):391-6. PubMed ID: 3668865
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.